Therapy of chronic myelogenous leukemia with interferon.
Kurzrock
R
R
Department of Clinical Immunology, University of Texas, M.D. Anderson Hospital and Tumor Institute, Houston.
Gutterman
J U
JU
Kantarjian
H
H
Talpaz
M
M
D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D013922:Thrombocytosis / Q000628:therapy
D007372:Interferons